Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 65 Nivolumab 56 Ipilimumab 34 Specimen Handling 23 Magnetic Resonance Spectroscopy 21 Cyclophosphamide 17 Biopsy 13 Radiosurgery 12 relatlimab 11 fludarabine 11 binimetinib 11 Opdualag 11 CTLA-4 Antigen 11 trametinib 10 fludarabine phosphate 8 dabrafenib 8 lifileucel 7 encorafenib 7 aldesleukin 7 atezolizumab 6 Interleukin-2 6 cemiplimab 5 X-Rays 5 Paclitaxel 5 Immunoglobulin G 5 Blood Specimen Collection 5 Taxes 4 Radiotherapy 4 Pemetrexed 4 Gemcitabine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Melanoma × secukinumab × 90 days × Clear all

NCT07237594 2026-06-04

REPLAY

Duke University

Phase 1 Recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡